Subscribe To
Glaxo (gsk) gets fda nod for hiv preventive injectable drug
Glaxo's (GSK) Apretude is the first and only long-acting injectable therapy approved for HIV prevention...
December 21, 2021, 1:50 pm
Glaxo (gsk) gets fda nod for hiv preventive injectable drug
Glaxo's (GSK) Apretude is the first and only long-acting injectable therapy approved for HIV prevention...
December 21, 2021, 1:50 pm
Glaxo (gsk) gets fda nod for hiv preventive injectable drug
Glaxo's (GSK) Apretude is the first and only long-acting injectable therapy approved for HIV prevention...
December 21, 2021, 1:50 pm
Delcath systems reveals initial survival data from ocular melanoma trial
Delcath Systems Inc (NASDAQ: DCTH) has announced results from the Phase 3 FOCUS study of Hepzato Kit (melphalan hydrochloride for ...
December 2, 2021, 1:27 pm
Delcath systems reveals initial survival data from ocular melanoma trial
Delcath Systems Inc (NASDAQ: DCTH) has announced results from the Phase 3 FOCUS study of Hepzato Kit (melphalan hydrochloride for ...
December 2, 2021, 1:27 pm
Delcath systems reveals initial survival data from ocular melanoma trial
Delcath Systems Inc (NASDAQ: DCTH) has announced results from the Phase 3 FOCUS study of Hepzato Kit (melphalan hydrochloride for ...
December 2, 2021, 1:27 pm
Municipal bond funds on track for record inflows in 2021
For the Refinitiv Lipper fund-flows week ended November 17, 2021, investors injected $1.4 billion into ...
November 21, 2021, 8:37 am
Municipal bond funds on track for record inflows in 2021
For the Refinitiv Lipper fund-flows week ended November 17, 2021, investors injected $1.4 billion into ...
November 21, 2021, 8:37 am
Municipal bond funds on track for record inflows in 2021
For the Refinitiv Lipper fund-flows week ended November 17, 2021, investors injected $1.4 billion into ...
November 21, 2021, 8:37 am
Why did oncorus shares slump to 52-week low today?
Oncorus Inc (NASDAQ: ONCR) shares slumped after the company reported initial data for its investigational cancer therapy ONCR-177 from a Phase 1 tria...
November 12, 2021, 1:24 pm
Why did oncorus shares slump to 52-week low today?
Oncorus Inc (NASDAQ: ONCR) shares slumped after the company reported initial data for its investigational cancer therapy ONCR-177 from a Phase 1 tria...
November 12, 2021, 1:24 pm
Why did oncorus shares slump to 52-week low today?
Oncorus Inc (NASDAQ: ONCR) shares slumped after the company reported initial data for its investigational cancer therapy ONCR-177 from a Phase 1 tria...
November 12, 2021, 1:24 pm
Protagonist therapeutics shares nearly doubled on monday: explore why
Shares of Protagonist Therapeutics Inc (NASDAQ: PTGX) nearly doubled on Monday as the U.S. FDA said it could resume the clinical trials for Rusfertide...
October 11, 2021, 11:16 am
Protagonist therapeutics shares nearly doubled on monday: explore why
Shares of Protagonist Therapeutics Inc (NASDAQ: PTGX) nearly doubled on Monday as the U.S. FDA said it could resume the clinical trials for Rusfertide...
October 11, 2021, 11:16 am
Protagonist therapeutics shares nearly doubled on monday: explore why
Shares of Protagonist Therapeutics Inc (NASDAQ: PTGX) nearly doubled on Monday as the U.S. FDA said it could resume the clinical trials for Rusfertide...
October 11, 2021, 11:16 am
Astrazeneca's injectable antibody cocktail halves risk of death or developing severe covid, trial finds
The British pharma firm has already asked U.S. regulators for emergency approval to use the antibody cocktail to prevent symptomatic Covid-19....
October 11, 2021, 5:53 am
Astrazeneca's injectable antibody cocktail halves risk of death or developing severe covid, trial finds
The British pharma firm has already asked U.S. regulators for emergency approval to use the antibody cocktail to prevent symptomatic Covid-19....
October 11, 2021, 5:53 am
Astrazeneca's injectable antibody cocktail halves risk of death or developing severe covid, trial finds
The British pharma firm has already asked U.S. regulators for emergency approval to use the antibody cocktail to prevent symptomatic Covid-19....
October 11, 2021, 5:53 am
Cytodyn has multiple shots on goal with its flagship drug vyrologix to treat hiv, various cancers and even coronavirus
CytoDyn's main product candidate is Vyrologix, an injectable antibody that shows promise as an anti...
October 10, 2021, 6:29 am
Cytodyn has multiple shots on goal with its flagship drug vyrologix to treat hiv, various cancers and even coronavirus
CytoDyn's main product candidate is Vyrologix, an injectable antibody that shows promise as an anti...
October 10, 2021, 6:29 am